BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20303260)

  • 1. A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.
    Aneja R; Miyagi T; Karna P; Ezell T; Shukla D; Vij Gupta M; Yates C; Chinni SR; Zhau H; Chung LW; Joshi HC
    Eur J Cancer; 2010 Jun; 46(9):1668-78. PubMed ID: 20303260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells.
    Karna P; Sharp SM; Yates C; Prakash S; Aneja R
    Mol Cancer; 2009 Oct; 8():93. PubMed ID: 19878573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering.
    Karna P; Rida PC; Pannu V; Gupta KK; Dalton WB; Joshi H; Yang VW; Zhou J; Aneja R
    Cell Death Differ; 2011 Apr; 18(4):632-44. PubMed ID: 21052096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
    Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice.
    Aneja R; Zhou J; Zhou B; Chandra R; Joshi HC
    Mol Cancer Ther; 2006 Sep; 5(9):2366-77. PubMed ID: 16985071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011.
    Aneja R; Zhou J; Vangapandu SN; Zhou B; Chandra R; Joshi HC
    Blood; 2006 Mar; 107(6):2486-92. PubMed ID: 16282340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity.
    Qin M; Peng S; Liu N; Hu M; He Y; Li G; Chen H; He Y; Chen A; Wang X; Liu M; Chen Y; Yi Z
    J Pharmacol Exp Ther; 2015 Dec; 355(3):473-83. PubMed ID: 26377911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.
    Aneja R; Liu M; Yates C; Gao J; Dong X; Zhou B; Vangapandu SN; Zhou J; Joshi HC
    Cancer Res; 2008 Mar; 68(5):1495-503. PubMed ID: 18316614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-toxic melanoma therapy by a novel tubulin-binding agent.
    Aneja R; Asress S; Dhiman N; Awasthi A; Rida PC; Arora SK; Zhou J; Glass JD; Joshi HC
    Int J Cancer; 2010 Jan; 126(1):256-65. PubMed ID: 19626589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protopine, a novel microtubule-stabilizing agent, causes mitotic arrest and apoptotic cell death in human hormone-refractory prostate cancer cell lines.
    Chen CH; Liao CH; Chang YL; Guh JH; Pan SL; Teng CM
    Cancer Lett; 2012 Feb; 315(1):1-11. PubMed ID: 22033245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesized 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells.
    Chou LC; Yang JS; Huang LJ; Wu HC; Lu CC; Chiang JH; Chen KT; Kuo SC; Chung JG
    J Gastroenterol; 2009; 44(10):1055-63. PubMed ID: 19688288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells.
    Yang JS; Hour MJ; Huang WW; Lin KL; Kuo SC; Chung JG
    J Pharmacol Exp Ther; 2010 Aug; 334(2):477-88. PubMed ID: 20463006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antimicrotubule therapy for prostate cancer.
    Pannu V; Karna P; Sajja HK; Shukla D; Aneja R
    Biochem Pharmacol; 2011 Feb; 81(4):478-87. PubMed ID: 21087597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis in prostate cancer cells.
    Nathwani SM; Cloonan SM; Stronach M; Campiani G; Lawler M; Williams DC; Zisterer DM
    Oncol Rep; 2010 Dec; 24(6):1499-507. PubMed ID: 21042745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAT-230, a Novel Microtubule Inhibitor, Induced Aberrant Mitosis and Apoptosis in SGC-7901 Cells.
    Qiao F; Zuo D; Wang H; Li Z; Qi H; Zhang W; Wu Y
    Biol Pharm Bull; 2013; 36(2):193-201. PubMed ID: 23370351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microtubule binding drug EM011 inhibits the growth of paediatric low grade gliomas.
    Ajeawung NF; Joshi HC; Kamnasaran D
    Cancer Lett; 2013 Jul; 335(1):109-18. PubMed ID: 23402815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line.
    Huang YT; Huang DM; Guh JH; Chen IL; Tzeng CC; Teng CM
    J Biol Chem; 2005 Jan; 280(4):2771-9. PubMed ID: 15536083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells.
    Acikgoz E; Guven U; Duzagac F; Uslu R; Kara M; Soner BC; Oktem G
    PLoS One; 2015; 10(10):e0141090. PubMed ID: 26485709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis.
    Gundala SR; Yang C; Mukkavilli R; Paranjpe R; Brahmbhatt M; Pannu V; Cheng A; Reid MD; Aneja R
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):86-96. PubMed ID: 25064160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.